IMMUNOGENIC TUMOR ANTIGENS: NUCLEIC ACIDS AND POLYPEPTIDES ENCODING THE SAME AND METHODS OF USE THEREOF

Title:

IMMUNOGENIC TUMOR ANTIGENS: NUCLEIC ACIDS AND POLYPEPTIDES ENCODING THE SAME AND METHODS OF USE THEREOF

Document Type and Number:

WIPO Patent Application WO2002088380

Kind Code:

A9

Abstract:

The invention provides human chronic myelocytic leukemia-like proteins (CML protein) and isolated nucleic acid molecules encoding the same. Also provided are antibodies that immunospecifically-bind to CML polypeptides or polynucleotides, or derivatives, variants, mutants, or fragments thereof. The invention additionally provides methods in which CML polypeptides, polynucleotides, and antibodies are used in the detection, prevention, and treatment of a broad range of pathological states, and methods of treating malignancy-related disorders by modulating activity or expression of CML proteins.

More Like This:

JP2014030427	METHODS AND COMPOSITIONS FOR DISEASES ASSOCIATED WITH AMYLOIDOSIS
WO/2024/026471	CD98HC ANTIGEN-BINDING DOMAINS AND USES THEREFOR
WO/2013/011135	CERAMIDE C16-CER AND CERS6 IN THE TREATMENT AND DIAGNOSIS OF MULTIPLE SCLEROSIS (MS)

Inventors:

RITZ JEROME (US)
YANG XIAO-FENG (US)
WU CATHERINE J (US)

Application Number:

PCT/US2002/013693

Publication Date:

April 29, 2004

Filing Date:

May 02, 2002

Export Citation:

Click for automatic bibliography generation Help

Assignee:

DANA FARBER CANCER INST INC (US)
RITZ JEROME (US)
YANG XIAO-FENG (US)
WU CATHERINE J (US)

International Classes:

A61K39/00; C07K14/47; C07K16/30; A61K38/00; (IPC1-7): A61K39/395; C07K16/00

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHODS AND COMPOSITIONS FOR UTILIZING CHANGES OF HYBRIDIZATION SIGNALS DURING APPROACH TO EQUILIBRI...

Next Patent: METHOD FOR DETERMINING GENE EXPRESSION